| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |